ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1351	National Cancer Institute	Html	en	Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of osteosarcoma and malignant fibrous histiocytoma of bone.	high-grade osteosarcoma patients 0.629145 co-operative German-Austrian-Swiss osteosarcoma 0.55607 neoadjuvant cooperative osteosarcoma 0.624122 pediatric osteosarcoma 0.57965 locally recurrent osteosarcoma 0.5543 Primary high-grade osteosarcoma 0.612176 parosteal osteosarcoma 0.568181 conventional osteosarcoma 0.56726 High grade osteosarcoma 0.599621 cooperative osteosarcoma study 0.792783 nonmetastatic osteosarcoma 0.60813 german-austrian-swiss osteosarcoma study 0.647756 high-grade osteosarcoma 0.738641 craniofacial osteosarcoma 0.630712 conventional high-grade osteosarcoma 0.570688 patients 0.646684 radiation-associated craniofacial osteosarcoma 0.580431 European Osteosarcoma Intergroup 0.58771 osteosarcoma incidence rate 0.594537 neoadjuvant chemotherapy 0.670909 high-grade extremity osteosarcoma 0.5876 Extraskeletal osteosarcoma 0.568579 Craniofacial osteosarcoma Experience 0.589537 Group Osteosarcoma Study 0.569569 radiation-related osteosarcoma 0.565185	osteosarcoma skip metastases 0.57865 synchronous multifocal osteosarcoma 0.617106 Osteosarcoma Intergroup study 0.567726 et al. 0.76197 PUBMED Abstract 0.575849 unresectable high-grade osteosarcoma 0.562489 primary osteosarcoma 0.586929 periosteal osteosarcoma 0.560798 osteosarcoma study group 0.793978 recurrent osteosarcoma 0.571668 non-metastatic osteosarcoma 0.633808 multi-institutional osteosarcoma study 0.604239 extremity osteosarcoma 0.634474 metastatic osteosarcoma 0.602383 multiinstitutional osteosarcoma study 0.587612 Abstract 0.808529 Clin Oncol 0.842874 operable osteosarcoma 0.589711 cooperative german-austrian-swiss osteosarcoma 0.615008 primary tumor 0.561916 intermediate-grade osteosarcoma 0.59029 Oncology Group 0.566747 cancer 0.596697 osteosarcoma 0.959056	CLICK HERE
1617	National Cancer Institute	Html	en	Chronic Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of chronic myeloproliferative neoplasms.	red blood cells 0.746761 chronic idiopathic myelofibrosis 0.40092 cancer treatment 0.416363 primary myelofibrosis 0.53957 PDQ cancer information 0.430215 bone marrow aspiration 0.385705 clinical trial search 0.421224 white blood cells 0.676519 chronic eosinophilic leukemia 0.451961 blood cells increases 0.444984 clinical trials 0.768861 chronic neutrophilic leukemia 0.40279 mature blood cells 0.434847 fewer blood cells 0.406923 cancer information summary 0.401424 clinical trial 0.500574 early signs 0.377313 patients 0.431687 blood cells 0.902472 blood vessels 0.37721 chronic myelogenous leukemia 0.406738 Treatment Editorial Board 0.377482 essential thrombocythemia 0.420345 treatment 0.55278 stored stem cells 0.37624	immature blood cells 0.399031 blood stem cell 0.37725 cancer cells 0.408902 -fighting blood cells 0.405086 lymphoid stem cell 0.374191 specific cancer cells 0.392312 chronic myeloproliferative neoplasms 0.69658 signs 0.38226 polycythemia vera 0.418683 patient 0.388228 treatment clinical trials 0.396123 blood stem cells 0.497004 National Cancer Institute 0.457233 routine blood test 0.45249 new treatment 0.393316 white blood cell 0.399685 extra blood cells 0.469808 bone marrow 0.605562 PDQ summary 0.382577 cancer clinical trials 0.425229 blood clots 0.392843 cancer 0.517448 information 0.439199 Myelogenous Leukemia Treatment 0.387746	CLICK HERE
1694	National Cancer Institute	Html	en	Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Patient Version	Childhood central nervous system (CNS) germ cell tumors form from germ cells (a type of cell that forms as a fetus develops and later becomes sperm in the testicles or eggs in the ovaries). Learn about the signs, tests to diagnose, and treatment of pediatric germ cell tumors in the brain in this expert-reviewed summary.	tumor marker levels 0.3628 cancer treatment 0.421684 Cell Tumors Treatment 0.421872 tumor marker 0.418943 blood tumor marker 0.368072 tumor marker tests 0.401497 germ cell tumor 0.574325 chemotherapy 0.377281 following PDQ summaries 0.365055 PDQ cancer information 0.426073 clinical trials 0.64034 Pediatric Treatment Editorial 0.365107 cancer information summary 0.398144 clinical trial 0.507274 childhood cns 0.519486 tumor markers 0.382879 CNS germ cell 0.581589 Extracranial Germ Cell 0.410121 different types 0.371541 NCI PDQ cancer 0.369493 radiation therapy 0.586685 Treatment Editorial Board 0.36802 Cord Tumors Treatment 0.393052 late effects 0.370411 treatment 0.581174	cancer cells 0.438925 treatment clinical trial 0.368062 PDQ Pediatric Treatment 0.363419 nervous system germ 0.412082 treatment clinical trials 0.389618 National Cancer Institute 0.397655 diagnose childhood CNS 0.382168 spinal cord 0.499499 tumor cells 0.386305 Germ cells tumors 0.441556 new treatment 0.423148 high tumor marker 0.363373 childhood cancer information 0.366666 external radiation therapy 0.366121 brain 0.390174 PDQ summary 0.396735 germ cell tumors 0.941151 cells 0.445231 cancer clinical trials 0.367524 stem cell rescue 0.36994 cancer 0.582086 standard treatment 0.367712 tumor marker level 0.399336 spinal cord tumors 0.390737	CLICK HERE
1893	National Cancer Institute	Html	es	Tratamiento de la leucemia linfoblástica aguda infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfoblástica aguda infantil.	posibles efectos tardíos 0.502603 células madre 0.665076 posibles factores 0.501536 adultos jóvenes 0.501533 leucemia linfocítica aguda 0.512291 alto riesgo 0.502688 Neurofibromatosis tipo 0.502438 leucemia linfoblástica aguda 0.9746 células madre formadoras 0.506563 siguientes especialistas 0.501875 hueso compacto 0.506303 neoplasias mieloides 0.501904 remisión ayuda 0.501645 enlace drugs approved 0.513331 cromosoma filadelfia 0.525108 célula madre mieloide 0.512145 células mieloides 0.511482 células t 0.515919 efectos tardíos 0.512683 Acute Lymphoblastic Leukemia 0.513739 PDQ Efectos tardíos 0.504379 líquido cefalorraquídeo 0.536807	punción espinal.Ampliar 0.501851 National Cancer Institute 0.501144 Instituto Nacional 0.503927 célula madre linfoide 0.505893 PDQ Tratamiento 0.503921 leucemia mielógena 0.507289 siguientes signos 0.502333 nuevos tipos 0.501266 Physician Data Query 0.504088 sistema nervioso central 0.50205 linfocitos t 0.507752 siguientes terapias 0.501163 leucemia mieloide aguda 0.536874 siguientes enlaces 0.501056 célula madre 0.527864 células sanguíneas maduras 0.513427 analizarse.Este procedimiento 0.501709 consolidación /intensificación 0.531485 Filadelfia".Ampliar Cromosoma Filadelfia 0.504086 ósea elabora células 0.51533 siguientes sumarios 0.503486 siguientes pruebas 0.502205	CLICK HERE
1918	National Cancer Institute	Html	es	Tratamiento del cáncer de vías biliares (colangiocarcinoma) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vías biliares.	pequeñas incisiones 0.429743 siguientes procedimientos 0.496942 pequeño número 0.430642 estadio iv 0.806715 IIIB.Estadio IIIA 0.428895 siguientes afecciones 0.443112 siguientes tipos 0.469726 múltiples tumores 0.426811 rayos x 0.429804 estadio ivb 0.620663 llama estadificación 0.509816 vías extrahepáticas distal 0.500664 rama derecha 0.425053 biliares extrahepáticas distal 0.562053 estadio iva 0.611281 quimioterapia sistémica 0.540152 National Cancer Institute 0.425091 quimioterapia sistémica ayuda 0.448855 colangiocarcinomas.ampliar anatomía 0.433411 estadios iiia 0.428062	siguientes riesgos 0.418955 estadio iib.estadio iia 0.483131 Instituto Nacional 0.443118 PDQ Tratamiento 0.452416 siguientes grupos 0.435798 vías biliares.Cáncer 0.522502 Colangiopancreatografía retrógrada 0.432583 marcador tumoral ca 0.457024 color arcilla 0.428813 fosfatasa alcalina 0.43337 siguientes factores 0.436523 partes distantes 0.435203 Physician Data Query 0.487514 estadio ib.estadio ia 0.481572 estadio iii 0.699586 antígeno carcinoembrionario 0.500245 biliar extrahepático distal 0.995606 medicamentos radiosensibilizadores 0.497933 pequeños conductos 0.46338 estadio ivb.estadio iva 0.489932	CLICK HERE
3440	National Cancer Institute	Html	es	Exámenes de detección del neuroblastoma (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el neuroblastoma.	Visuals Online 0.563675 PDQ Exámenes 0.77452 Physician Data Query 0.971175 ecografía fetal 0.642315 prevención revisa 0.581226 graves riesgos 0.622769	presente síntomas 0.605798 información ayuda 0.590632 cuáles tipos 0.60865 National Cancer Institute 0.613572 siguientes riesgos 0.582879 Instituto Nacional 0.71673	CLICK HERE
3443	National Cancer Institute	Html	es	Prevención del cáncer de cavidad oral y orofaringe (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de labio, cavidad oral y orofaringe, y sobre las investigaciones dirigidas a prevenir esta enfermedad.	área pequeña detrás 0.802445 mastique betel 0.744682 Visuals Online 0.640815 voluntarios sanos 0.673012 rojo anormal 0.920245 Physician Data Query 0.914313 suficiente ejercicio 0.702729	prevención revisa 0.679375 siguientes tejidos 0.731332 PDQ Prevención 0.725434 National Cancer Institute 0.673463 siguientes riesgos 0.652028 Instituto Nacional 0.74458	CLICK HERE
3851	National Cancer Institute	Html	en	Treating Cancer without Harming the Heart	Researchers from the fields of oncology and cardiology are working to find ways to prevent, manage, and possibly even reverse the cardiovascular side effects of certain cancer therapies.	childhood cancers 0.722954 cardiovascular changes 0.633513 cancer treatment-related cardiotoxicity 0.773654 ischemic heart disease 0.641571 research 0.740587 task force 0.629922 childhood cancer increases 0.668587 cardiac health 0.652664 heart problems 0.663961 heart failure 0.684862 risk factors 0.812151 certain cardiac functions 0.66508 Community Oncology Research 0.635145 ischemic cardiac disease 0.673041 breast cancer patients 0.750275 adult survivors 0.677672 heart 0.763054 breast cancer trial 0.667286 Prevention Trials Research 0.631942 radiation therapy 0.716677 childhood cancer 0.74187 cancer treatments 0.731665 childhood cancer treatments 0.686861 study 0.637136	community oncology 0.686779 cancer treatment—chemotherapy agents 0.673113 cardiac side effects 0.698632 Anderson Cancer Center 0.750363 early cardiac dysfunction 0.678902 new research strategies 0.65852 trastuzumab-related cardiac events 0.724465 Dana-Farber Cancer Institute 0.652906 Community Oncology Cardiotoxicity 0.640076 cardiac risk factors 0.767014 subsequent research agendas 0.636051 cardiac adverse effects 0.710556 MD Anderson Cancer 0.75179 cardiac arrhythmia 0.64223 NCI Community Oncology 0.685131 NCI-supported cardiotoxicity studies 0.649029 breast cancer 0.957268 treatment-induced cardiac disease 0.677462 NCI community-based oncology 0.638369 breast cancer treatments 0.671567 Vanderbilt-Ingram Cancer Center 0.655353 cancer clinical trials 0.814235 underlying cardiovascular risk 0.658241 cardiovascular problems 0.640023	CLICK HERE
16599	National Cancer Institute	Html	es	Actividad física y cáncer	Hoja informativa que resume la evidencia que relaciona el ejercicio y otras actividades físicas, incluso el trabajo y tareas domésticas, para reducir los riesgos de cáncer.	physical activity trials 0.609757 with risk 0.60318 12). La actividad 0.606743 actividad física. Estas 0.606316 British Journal 0.604503 Jochem C 0.601681 Breast Cancer Research 0.606153 Leitzmann MF 0.603331 vigorous physical activity 0.609704 Polyp Prevention Trial 0.601597 mortality among breast 0.602477 physical activity guidelines 0.609758 physical activity with 0.609915 postdiagnosis physical activity 0.608948 7). La actividad 0.606768 Internal Medicine 0.603799 distal colon cancers 0.601731 actividad física 0.987182 PubMed Abstract 0.847996 NIH-AARP Diet 0.601986 Clinical Oncology 0.601841 Cancer Journal 0.605637 International Journal 0.60436 Courneya KS 0.60156 Does physical activity 0.60988	actividad física. La 0.606304 Arem H 0.601596 cancer prevention 0.614687 Schmid D 0.60334 semana. La actividad 0.606319 British Medical Journal 0.601693 Behrens G 0.608768 física causa cáncer 0.609492 gastrointestinal cancers 0.608366 Health Study 0.605366 Cancer Research 0.607712 actividad física. Sin embargo 0.606177 reducción promedio 0.602018 breast cancer 0.663645 Cancer Survivorship 0.604816 systematic review 0.658042 Keimling M 0.603345 physical activity 0.836944 Eliassen AH 0.601741 mejores resultados 0.60425 Cancer Institute 0.60845 Colditz GA 0.601647 Ballard-Barbash R 0.60156 recreational physical activity 0.616085	CLICK HERE
16851	National Cancer Institute	Html	es	Sulfato de hidracina (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso del sulfato de hidracina como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.533358 determinados efectos 0.530508 New Hampshire Avenue 0.523784 siguientes aspectos 0.523737 Drug Administration 0.514799 patients with weight 0.533925 NCI Best Case 0.549835 diagnosed non-small-cell lung 0.536234 Grosvenor M 0.517103 datos bibliográficos pubmed 0.525622 siguientes preguntas 0.515807 Heber D 0.517667 siguientes riesgos 0.519241 Instituto Nacional 0.7207 Su JQ 0.518581 Salud Complementaria 0.556196 Visuals Online 0.516984 siguientes resultados 0.521312 curso estudios 0.529991 complementarias revisa 0.524603	Clin Oncol 0.521025 Physician Data Query 0.597613 Goldberg RM 0.517983 PDQ Sulfato 0.709455 Estados Unidos 0.833671 Chlebowski RT 0.553534 breakdown measured 0.519564 libre uso 0.517176 compañía farmacéutica 0.520309 página manejo 0.515736 ¿El tratamiento 0.532073 Bulcavage L 0.518136 patients with 0.551924 siguientes datos 0.520348 ¿Los beneficios 0.514828 juntos cam 0.514239 Funcionamiento motor 0.518326 Tayek JA 0.519355 Series Program 0.514501 medicina complementaria 0.982503	CLICK HERE